Guidelines for use of antirheumatic drugs.
The Vth WHO/ILAR Task Force Meeting on Rhemuatic Diseases ratified guidelines for the use of antirheumatic drugs. Indications for use, contraindications, dose, administration and other usage principles, toxicity, and advice to patients have been agreed for analgesics, nonsteroidal antiinflammatory drugs, slower acting antirheumatic drugs, corticosteroids, and hypouricemic agents.
Russell
A S
AS
Department of Medicine, University of Alberta, Edmonton, Canada.
Darmawan
J
J
Scott
D L
DL
Brooks
P M
PM
Hubscher
O
O
D000305:Adrenal Cortex Hormones / Q000009:adverse effects / Q000627:therapeutic use; D000700:Analgesics / Q000009:adverse effects / Q000627:therapeutic use; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects / Q000627:therapeutic use; D018501:Antirheumatic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D017408:Guidelines as Topic; D006801:Humans; D012216:Rheumatic Diseases / Q000188:drug therapy*
D000305:Adrenal Cortex Hormones; D000700:Analgesics; D000894:Anti-Inflammatory Agents, Non-Steroidal; D018501:Antirheumatic Agents